This research has resulted in the development of an implantable drug delivery device (ChemoSeed®) for the local delivery of personalised chemotherapy regimens.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

(RTTNews) - Clearmind Medicine Inc. (CMND), Wednesday announced ... to develop a novel intranasal formulation for its psychedelic-based treatment applications. Under the partnership, the companies ...

In the vast realm of traditional Chinese medicine (TCM), there are countless formulations that have stood the test of time, proving their efficacy and value across centuries. One such formulation ...

Mind Medicine recently launched a Phase 3 trial ... 2041 by obtaining a patent for an orally disintegrating tablet (ODT) ...

Ayurveda, a centuries-old practice, has been an important part of traditional medicine in India, offering holistic healing ...

About Bio-Convert Bio-Convert’s mission is to develop the preferred treatment for oral leukoplakia. Our innovative therapeutic agent, QR-02, uses a novel drug delivery technology, that enables more ...

The recommended target dose is 10 mg twice daily. The US FDA recently approved an extended-release (ER) formulation of memantine for once-daily 28-mg dosing. Memantine ER was evaluated in a 24 ...

A new tablet formulation of SMA treatment Evrysdi (risdiplam) may give patients more "freedom and independence," a Genentech ...

Joel Friedman, M.D., Ph.D., professor of microbiology & immunology and of medicine at Albert Einstein ... and easy to use formulation that can be deployed over an extended period of time that ...